{"id":3752,"date":"2018-01-24T17:05:15","date_gmt":"2018-01-24T22:05:15","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3752"},"modified":"2018-01-24T17:05:15","modified_gmt":"2018-01-24T22:05:15","slug":"secondaries-announced-1-24-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-1-24-18\/","title":{"rendered":"Secondaries Announced 1.24.18"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: Five Prime Therapeutics
\nSymbol: FPRX
\nPrice: Last Trade $22.43
\nTrade Date: 1\/25
\nShares: 3.4 million ($75m cash raise)
\nUnderwriter(s): Goldman Sachs & Co., J.P. Morgan, Leerink Partners, Wells Fargo
\nDescription: They are a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: ConforMIS, Inc.
\nSymbol: CFMS
\nPrice: Last Trade $2.27
\nTrade Date: 1\/25
\nShares: 8.9 million ($20 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Cowen, Canaccord Genuity
\nDescription: ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient’s unique anatomy.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Albireo Pharma, Inc.
\nSymbol: ALBO
\nPrice: Last Trade $35.76
\nTrade Date: 1\/25
\nShares: 1.4 million ($50m cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Cowen, William Blair
\nCo-Manager(s): Needham, Wedbush PacGrow, Roth Capital
\nDescription: Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Ocular Therapeutix Inc.
\nSymbol: OCUL
\nPrice: Last Trade $6.19
\nTrade Date: 1\/25
\nShares: 4.8 million ($25 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Piper Jaffray
\nDescription: They are a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology.
\nRating =\u00a0Subscription Needed<\/a><\/strong><\/p>\n

Company: Iovance BioTherapeutics, Inc.
\nSymbol: IOVA
\nPrice: Last Trade $11.50
\nTrade Date: 1\/25
\nShares: 10.9 million ($125m cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Jefferies
\nDescription: They are a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Blink Charging Co.
\nSymbol: BLNK
\nPrice: Last Trade: N\/A
\nTrade Date: 1\/30
\nShares: 4.6 million
\nUnderwriter(s): Joseph Gunnar
\nCo-Manager(s): Benchmark, Dawson James Securities
\nDescription: Blink Charging Co. is a leading owner, operator, and provider of electric vehicle charging equipment and networked EV charging services. Their Common Stock is presently quoted on the OTC Pink Current Information Marketplace under the symbol “CCGI”. Each unit consisting of one share of common stock and one warrant to purchase one share of common stock.The warrants included within the units are exercisable immediately, have an exercise price of 150% of the public offering price of one unit, and expire five years from the date of issuance.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

\"Screen<\/a><\/p>\n

Company: The Williams Company – Block
\nSymbol: WMB
\nPrice: Last Trade $33.10
\nTrade Date: 1\/25
\nShares: 8.6 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Morgan Stanley
\nDescription: The Williams Companies, Inc. operates as an energy infrastructure company primarily in the United States.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-3752","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3752"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3752\/revisions"}],"predecessor-version":[{"id":3754,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3752\/revisions\/3754"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}